Determinants of Antiviral Treatment Initiation in a Hepatitis C-infected Population Benefiting from Universal Health Care Coverage

Determinants of Antiviral Treatment Initiation in a Hepatitis C-infected Population Benefiting from Universal Health Care Coverage

BACKGROUND AND AIMS: In view of increasing therapeutic efficacy, the delivery of hepatitis C virus (HCV) antiviral treatment is expected to increase. Yet practical experience reveals a low rate of treatment, particularly among intravenous drug users. The aim of the present study was to examine the p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Romain Moirand, Marc Bilodeau, Suzanne Brissette, Julie Bruneau
Format:	Article
Language:	English
Published:	Wiley 2007-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2007/576765
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recent Advances in Antiviral Therapy for Chronic Hepatitis C
by: Akihiro Tamori, et al.
Published: (2016-01-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

KSHV hijacks the antiviral kinase IKKε to initiate lytic replication.
by: Xiaoqian Wang, et al.
Published: (2025-01-01)

Government Support for Universities: Regional Coverage
by: V. L. Parkacheva, et al.
Published: (2022-06-01)

Universality of universal health coverage: A scoping review.
by: Aklilu Endalamaw, et al.
Published: (2022-01-01)

Community engagement initiatives in primary health care to achieve universal health coverage: A realist synthesis of scoping review.
by: Daniel Erku, et al.
Published: (2023-01-01)

Successful Antiviral Treatment with Direct-Acting Antivirals for Hepatitis C Virus Infection during Peritransplant Period in a Kidney Transplant Recipient
by: Giovanni Varotti, et al.
Published: (2021-01-01)

Antiviral therapy for chronic hepatitis C: is there a time to change existing standards?
by: D. T. Abdurakhmanov
Published: (2009-02-01)

Predictors of Antiviral Therapy in a Post-Transfusion Cohort of Hepatitis C Patients
by: Maciej Witkos, et al.
Published: (2006-01-01)

Elderly Patients Are at Greater Risk of Cytopenia During Antiviral Therapy for Hepatitis C
by: CG Nudo, et al.
Published: (2006-01-01)

Biochemical Evolution and Histological Response of Patients with Hepatitis C Undergoing Antiviral Therapy.
by: Omar Julián Hernández Ojeda, et al.
Published: (2011-07-01)

Impact of hepatic steatosis on the efficacy of antiviral treatment for chronic hepatitis B and the establishment of predictive model: a cohort study
by: Guanghui Ren, et al.
Published: (2025-02-01)

Two ways to one goal: new strategy of antiviral therapy for chronic hepatitis C
by: S. N. Batskikh
Published: (2012-11-01)

Sarcoid-like reaction at the patient with chronic hepatitis C on a background of antiviral therapy
by: A. V. Lapshin, et al.
Published: (2010-06-01)

Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C: Open Issues and Future Perspectives
by: Hee Bok Chae, et al.
Published: (2013-01-01)

Viral Response to Specifically Targeted Antiviral Therapy for Hepatitis C and the Implications for Treatment Success
by: Curtis L Cooper
Published: (2010-01-01)

Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
by: Sylvia Drazilova, et al.
Published: (2018-01-01)

Universal Health Coverage in Bangladesh: Activities, Challenges, and Suggestions
by: Taufique Joarder, et al.
Published: (2019-01-01)

In Vitro Determination of Antimicrobial, Antioxidant and Antiviral Properties of Greek Plant Extracts
by: Aliki Tsakni, et al.
Published: (2025-01-01)

The modern options of chronic hepatitis C antiviral therapy with daclatasvir: results of named patient program
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Long-term results of antiviral therapy in patients with chronic hepatitis C with sustained virologic response
by: T. M. Ignatova, et al.
Published: (2013-09-01)

Liver Cell Death: Update on Apoptosis
by: Marc Bilodeau
Published: (2003-01-01)

Knowledge and awareness of perinatal antiviral use in the prevention of mother-to-child hepatitis B virus transmission among maternal chronic hepatitis carriers
by: Jia Ming Low, et al.
Published: (2024-09-01)

Differentiated approach at the choice of chronic hepatitis C antiviral therapy mode (real clinical practice experience)
by: I. Yu. Pirogova, et al.
Published: (2018-08-01)

Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C
by: L. Tang, et al.
Published: (2018-01-01)

The Second Canadian Symposium on Hepatitis C Virus: A Call to Action
by: Jason Grebely, et al.
Published: (2013-01-01)

The impact of same‐day and rapid ART initiation under the Universal Health Coverage programme on HIV outcomes in Thailand: a retrospective real‐life cohort study
by: Sirinya Teeraananchai, et al.
Published: (2025-01-01)

Performance-based financing is not on the path towards universal health coverage and equity
by: Elisabeth Paul, et al.
Published: (2025-01-01)

Directions, benefits, and digitalisation effectiveness determining
by: O. A. Zemlyanskiy
Published: (2022-06-01)

Direct-Acting Antivirals in Hepatitis C Treatment for Renal Impairment: Liver Safety Concerns and Effectiveness in Peritoneal Dialysis
by: Hsuan-Yu Hung, et al.
Published: (2024-12-01)

Prevalence of Frailty Indicators and Association with Socioeconomic Status in Middle-Aged and Older Adults in a Swiss Region with Universal Health Insurance Coverage: A Population-Based Cross-Sectional Study
by: Idris Guessous, et al.
Published: (2014-01-01)

Community Participation in Programme Planning for Universal Health Coverage in India: An exploratory study
by: Yogesh Chandra, et al.
Published: (2025-02-01)

Real-life study on the effectiveness and safety of sofosbuvir/velpatasvir-based antiviral agents for hepatitis C eradication in Chinese patients
by: Jiayi Wang, et al.
Published: (2024-12-01)

Five-Year Prospective Follow-Up of Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antiviral Agents
by: Zhang Y, et al.
Published: (2025-01-01)

Miliary Tuberculosis Initially Presenting as an Isolated Hepatic Abscess
by: Chang Won Ha, et al.
Published: (2025-01-01)

Mode of Transmission, Rather than the Hepatitis C Virus, as a Major Determinant of Poor Interpersonal Relationships in Patients with Chronic Hepatitis C
by: Thuy Phuong La, et al.
Published: (2007-01-01)

Management of Anticoagulation for Portal Vein Thrombosis in Individuals with Cirrhosis: A Systematic Review
by: Geneviève Huard, et al.
Published: (2012-01-01)

Considering the nutritional benefits and health implications of red meat in the era of meatless initiatives
by: Melissa Kavanaugh, et al.
Published: (2025-01-01)

Policy innovation to enhance access to universal health coverage: A case of Kota Semarang
by: Hanani Retna, et al.
Published: (2025-01-01)

Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study
by: Guilherme Thomé de Carvalho, et al.
Published: (2025-02-01)